This article was originally published in The Gray Sheet
Acquisition of Laser Skin Toner for roughly 1.7 mil. shares of BioLase stock is valued at about $6 mil. LST's laser "no-incision facelift" and stretch-mark removal system, which is currently pending FDA clearance, is anticipated to round out BioLase's newly formed Aesthetic Division and complement its DermaLase hydrokinetic system and Lazer ToothBrush tooth-whitening system, BioLase states
You may also be interested in...
Philips will pay $635m for the Massachusetts-based developer of a platform that connects medical devices and electronic medical records in hospitals.
Final guidance, for pharmaceutical alcohol used as an active or inactive ingredient in other drugs as well as hand sanitizers, “will help pharmaceutical manufacturers avoid using pharmaceutical alcohol contaminated with or substituted with methanol in drug products.”
Proposal, which could be formally endorsed by MedPac this spring, would lower the payment rates for vaccines while simultaneously moving all preventative vaccine coverage to Medicare Part B. Commission signals further cuts to payment rate, through an average sales priced-based methodology might eventually be recommended.